Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Pipeline and Commercial Insight: Parkinson's Disease' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| GPCRs in Drug Discovery Efforts to De-Orphanize Novel Gpcr Targets Are Increasing |
Nov 2011 | £2,215 | 100% |
| Gene Therapy | Jan 2011 | £2,845 | 95% |
| Delivering RNAi-Based Therapeutics & Diagnostics Challenges & Opportunities |
Jul 2009 | £945 | 84% |
| Stryker Corporation Product Pipeline Analysis | Jan 2009 | £475 | 82% |
| Neuromodulation Devices: World Market Prospects 2011-2021 |
Oct 2011 | £1,699 | 81% |
| Companion Biomarkers in Drug Development | Apr 2009 | £2,150 | 75% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 71% |
| Biomedical Imaging From Drug Target Discovery to Medical Diagnostics |
Dec 2008 | £2,370 | 70% |
| Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
Jul 2007 | £1,999 | 64% |
| Biomarkers | Aug 2011 | £3,035 | 60% |
| United States Diagnostic Imaging Market Outlook to 2017 Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others |
Sep 2011 | £1,580 | 54% |
- Results 1 - 11 of 11
-
-
- 1
-
-
